Skip to content
Screener

Geron GERN Total gross-to-net adjustments — Total revenues

Other product segments

Gross product revenue
$72.44M+25.2%
Chargebacks
-$9.19M
Distributor service fees
-$2.37M
Government rebates
-$1.97M-329%
Sales returns and allowances
-$1.43M-177%

Similar metrics at other companies

Rhythm Pharmaceuticals, Inc. logo
RYTMProduct revenue, net — Total revenues
$60.11M+59.4%
Exelixis logo
EXELGross product revenues — Total revenues
$812.78M+9.1%
Hyatt Hotels logo
HGross fees — Total revenues
$334M+7.1%
Vertex Pharmaceuticals logo
VRTXTotal CF product revenues, net — Total revenues
$3.21B
comScore logo
SCORCross-Platform — Total revenues
$12.6M+30.4%
ALN
ALNYRoyalty revenue — Total revenues
$71.67M+79.3%

Other financials

Income statement

See full
Revenue$57.5M+17.2%
Operating income-$12.5M-0.3%
Net income-$16.7M-1.9%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$64.5M-18.9%
Total debt$134.1M-0.3%
Total equity$218.6M-15.8%
Total assets$519.0M-6.5%

Cash flow

See full
Operating cash flow-$15.8M+42.3%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$1.01B+9.4%
Enterprise value$1.08B+10.4%
P/S4.9×-180×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-28.3%-2.3pp
Debt / equity0.6×+0.1×
Current ratio6.9×-1.0×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Geron’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:41 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000886744-26-000037
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Gross product revenue$72,436$57,874$137,789$103,186
Gross-to-net adjustments:
Chargebacks(9,190)(5,940)(17,354)(10,111)
Distributor service fees(2,371)(1,950)(4,540)(3,476)
Government rebates(1,969)(459)(3,627)(525)
Sales returns and allowances(1,433)(518)(3,024)(631)
Total gross-to-net adjustments(14,963)(8,867)(28,545)(14,743)
Net product revenue$57,473$49,007$109,244$88,443

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Geron's total gross-to-net adjustments — total revenues?
Geron (GERN) reported total gross-to-net adjustments — total revenues of -$14.96M in Q2 2026.
How has Geron's total gross-to-net adjustments — total revenues changed year-over-year?
Geron's total gross-to-net adjustments — total revenues decreased by 68.7% year-over-year, from -$8.87M to -$14.96M.
What does total gross-to-net adjustments — total revenues mean?
This metric represents the aggregate value of deductions applied to gross product sales, including rebates, chargebacks, discounts, and returns, to arrive at net revenue. It serves as a critical indicator of the difference between the invoiced price and the actual realized revenue recognized by the company. Monitoring these adjustments provides insight into pricing pressure, contractual obligations with payers, and the overall net realization rate of the product portfolio.

Ask your AI about Geron's total gross-to-net adjustments — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude